Why the study?
Does interleukin-4 reduce TNF-alpha induced expression of tissue factor and PAI-1 in human umbilical vein endothelial cells?
Does interleukin-4 reduce TNF-alpha induced expression of tissue factor and PAI-1 in human umbilical vein endothelial cells?
IL-4 inhibits TNF-alpha-induced pro-coagulant tissue factor expression but not anti-fibrinolytic PAI-1 production in human endothelial cells, suggesting a specific regulatory role in vascular inflammation.
Answers are grounded in this paper and cite their sources.
IL-4 selectively inhibits endothelial TF expression in vitro; hypothesis-generating for vascular inflammation modulation, requiring in vivo confirmation before any clinical consideration.
The pro-inflammatory cytokine tumour necrosis factor-alpha (TNF-alpha) is able to alter the haemostatic balance of human umbilical vein endothelial cells (HUVECs) towards that of a procoagulant and anti-fibrinolytic state. Treatment of HUVECs in culture with human recombinant TNF-alpha (0.5-50 U/ml; 6 h) significantly increased total cell expression of tissue factor (TF) 10-fold from 40 mU/well to 400-500 mU/well. Levels of plasminogen activator inhibitor-1 (PAI-1) antigen secreted from HUVECs also increased up to 2-fold in concentration-dependent fashion following addition of TNF-alpha (10-100 U/ml; 24 h). TNF-alpha induced total and cell surface expression of TF on HUVECs was significantly inhibited when the cells were pre-incubated with interleukin-4 (IL-4; p < 0.001). This effect was time and concentration dependent. Pretreatment of HUVECs with IL-4 for 4 h had no significant effect, but increasing inhibition of total TF expression occurred after 8 and 16 h pre-incubations. Treatment with IL-4 at 20 and 200 U/ml significantly inhibited cell surface TF responses induced by TNF-alpha, whereas a low concentration (0.2 U/ml) was without effect. In contrast, the production of PAI-1 from HUVECs stimulated by TNF-alpha (50 U/ml) was unaffected by the presence and/or prior incubation with 200 U/ml IL-4. Thus, IL-4 may regulate the pro-coagulant but not the antifibrinolytic effects of TNF-alpha at sites of vascular inflammation.
No takes yet. Share an insight, caveat, or question.
Martin et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: